Dr. Michael Stifelman, MD

Dr. Stifelman practices at Hmhmg Specialty Care in Hackensack, New Jersey.

Dr. Stifelman's NPI, 1750375564, was assigned on September 7, 2005. Dr. Stifelman graduated from Albert Einstein College of Medicine of Yeshiva University in 1993. Dr. Stifelman holds New Jersey license 25MA06982600.

Dr. Stifelman's primary practice is Hmhmg Specialty Care, at 360 Essex St Ste 401 Suite 401, Hackensack, NJ 07601. The practice phone is (551) 996-1140.

Dr. Stifelman's primary practice is Hmhmg Specialty Care in Hackensack, New Jersey. Dr. Stifelman is also affiliated with Hackensack University Medical Center. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Stifelman to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stifelman practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Stifelman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Stifelman is licensed in New Jersey.

CMS data shows 623 Medicare services from Dr. Stifelman across 12 procedure codes in 2024, for 319 Medicare patients. Medicare paid $91,059 for them.

CMS counts 319 Medicare patients who saw Dr. Stifelman in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stifelman's median patient age at 68, with 27% women.

In 2024, Dr. Stifelman wrote 139 Medicare Part D claims for 51 patients. 83% of them were for generic drugs. CMS names the drug for 91 of them, across 4 drugs with 11 or more claims each, at $13,663 in total drug cost. In 2023, CMS named 72 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Stifelman for performance year 2024, reported as part of a group. Dr. Stifelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stifelman as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Stifelman, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Stifelman, published from 2014 to 2025. 2023 was the busiest year, with 13. The most frequent topics are Robotic Surgical Procedures, Nephrectomy and Kidney Neoplasms. Dr. Stifelman has published most often in Urology. Dr. Stifelman's most frequent co-authors are Mutahar Ahmed, MD, Ketan K. Badani, MD and Daniel D. Eun, MD.

CMS Open Payments shows 661 general payments to Dr. Stifelman from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Vascular Technology, Inc. paid the most, $930,347. It also lists 3 research payments totaling $122,423 in 2020.

Dr. Stifelman graduated from Albert Einstein College of Medicine of Yeshiva University in 1993.